Bit Capital Gmb H Immatics N.V. Transaction History

Bit Capital Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$6.73 - $11.21 $343,916 - $572,853	-51,102 Closed	0 $0
Q3 2024 Feb 12, 2025	BUY	$10.93 - $12.92 $558,544 - $660,237	51,102 New	51,102 $583 Million
Q1 2024 Feb 12, 2025	SELL	$10.23 - $12.94 $97,430 - $123,240	-9,524 Closed	0 $0
Q4 2023 Feb 12, 2025	BUY	$7.36 - $10.89 $32,244 - $47,709	4,381 Added 85.18%	9,524 $100 Million
Q3 2023 Feb 12, 2025	BUY	$11.01 - $12.62 $56,624 - $64,904	5,143 New	5,143 $59.6 Million

102

78.3M

238K

727K

Ticker IMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,227,000
Market Cap $377M
Description
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...

Get notified when there are updates to the investment portfolio of Bit Capital Gmb H, based on Form 13F filings with the SEC.

Stay updated on Bit Capital Gmb H with notifications on news.